CHICAGO EQUITY PARTNERS LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q1 2020$333,000
-55.7%
5,890
-55.3%
0.03%
-20.9%
Q4 2019$751,000
-31.8%
13,186
-35.9%
0.04%
-17.3%
Q3 2019$1,101,000
+46.2%
20,571
+63.2%
0.05%
+52.9%
Q2 2019$753,000
-5.4%
12,606
-1.3%
0.03%
+9.7%
Q1 2019$796,000
+23.6%
12,771
-7.7%
0.03%
+55.0%
Q3 2017$644,000
-1.7%
13,835
+4.6%
0.02%
+11.1%
Q2 2017$655,000
-8.9%
13,225
+0.8%
0.02%
-14.3%
Q1 2017$719,000
+35.2%
13,115
+37.3%
0.02%
+50.0%
Q4 2016$532,0009,5500.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders